Federal Register / Vol. 55, No. 179 / Friday, September 14, 1990 / Notices 
37965 
Written comments and 
recommendations for the proposed 
information should be sent directly to 
the appropriate OMB Desk Officer 
designated above at the following 
address: OMB Reports Management 
Branch, New executive Office Building. 
Room 3201, 725 17th Street, NW., 
Washington, DC 20503. 
Dated: September 4, 1990. 
Naomi B. Marr, 
Associate Administrator, Office of - 
Management and Information Systems, FSA. 
[FR Doc.SO-21603 Filed 9-13-90: 8:45 am] 
BILUNG CODE 4150-04-M 
National Institutes of Health 
Revision of NIH Guidelines 
Subcommittee; Meeting 
Pursuant to Public Law 92-463, notice 
is hereby given of a meeting of the 
Revision of NIH Guidelines 
Subcommittee (a subcommittee of the 
Recombinant DNA Advisory 
Committee) on October 15, 1990. The 
meeting will be held at the Bethesda 
Marriott Hotel, 5151 Pooks Hill Road, 
Bethesda. Maryland 20814, starting at 
approximately 7 p.m. to adjournment at 
approximately 9:30 p.m. 
The meeting will be open to the public 
to discuss the following proposed action 
under the NIH Guidelines for Research 
Involving DNA Molecules (51 FR 16958): 
Revision of appendix K of the “NIH 
Guidelines” Regarding Establishment of 
Guidelines for Level of Containment 
Appropriate to Good Industrial Large 
Scale Practices (GILSP). In a letter dated 
June 28, 1990, the Industrial 
Biotechnology Association (IBA) and the 
Pharmaceutical Manufacturers 
Association (PMA) requested that the 
Recombinant DNA Advisory Committee 
revise appendix K of the NIH Guidelines 
for Research Involving Recombinant 
DNA Molecules to reflect a 
formalization of suitable containment 
practices and facilities for the conduct 
of large-scale experiments involving 
recombinant DNA-derived industrial 
microorganisms. In attachments to this 
request, there are proposed definitions 
and requirements pertaining to the 
requested changes. The Revision of the 
NIH Guidelines Subcommittee will 
report with a recommendation to the 
Recombinant DNA Advisory Committee 
during their meeting on October 16, 1990; 
Other Matters To Be Considered by the 
Committee 
Attendance by the public will be 
limited to space available. Members of 
the public wishing to speak at this 
meeting may be given such opportunity 
at the discretion of the Chair. 
Dr. Nelson A. Wivel, Director, Office 
of Recombinant DNA Activities, 
National Institutes of Health, Building 
31, room 4B11, Bethesda, Maryland 
20892, telephone (301) 496-9838, fax 
(301) 490-9839, will provide materials to 
be discussed at this meeting, roster of 
committee members, and substantive 
program information. A summary of the 
meeting will be available at a later date. 
OMB’s "Mandatory Information 
Requirements for Federal Assistance 
Program Aimouncements" (45 FR 39592, 
June 11, 1980) requires a statement 
concerning the oMcial government 
programs contained in the Catalog of 
Federal Domestic Assistance. Normally 
NIH lists in its announcements the 
number and title of affected individual 
programs for the guidance of the public. 
Because the guidance in this notice 
covers not only virtually every NIH 
program but also essentially every 
Federal research program in which DNA 
recombinant molecule techniques could 
be used, it has been determined not to 
be cost effective or in the public interest 
to attempt to list these programs. Such a 
list would likely require several 
additional pages. In addition, NIH could 
not be certain that every Federal 
program would be included as many 
Federal agencies, as well as private 
organizations, both national and 
international, have elected to follow the 
NIH Guidelines. In lieu of the individual 
program listing, NIH invites readers to 
direct questions to the information 
address above about whether individual 
programs listed in the Catalog of 
Federal Domestic Assistance are 
affected. 
Dated; September 10, 1990. 
Betty ]. Beveridge, 
Committee Management Officer, NIH. 
[FR Doc. 90-21710 Filed 9-13-90; 8:45 am] 
BILLING CODE 4140-01-M 
National Institute of Allergy and 
Infectious Diseases; Meeting of 
Pursuant to Public Law 92-463, notice 
is hereby given of the meeting of the 
Allergy and Clinical Immunology 
Subcommittee of the Allergy, 
Immunology, and Transplantation 
Research Committee, National Institute 
of Allergy and Infectious Diseases, on 
October 22, 1990, in Conference Room 9, 
Building 31C, at National Institutes of 
Health, Bethesda, Maryland 20892. 
The meeting will be open to the public 
from 8:30 a.m. to 10 a.m. on October 22, 
to discuss administrative details relating 
to committee business and for program 
review. Attendance by the public will be 
limited to space available. In 
accordance with the provisions set forth 
in secs. 552b(c)(4) and 552b(c)(6), title 5, 
U.S.C. and sec. 10(d) of Public Law 92- 
463, the meeting will be closed to the 
public for the review, discussion, and 
evaluation of individual grant 
applications and contract proposals 
from 10 a.m. on October 22 until 
adjournment. These applications, 
proposals, and the discussions could 
reveal confidential trade secrets or 
commercial property such as patentable 
material and personal information 
concerning individuals associated with 
the applications and proposals, the 
disclosure of which would constitute a 
clearly unwarranted invasion of 
personal privacy. 
Ms. Patricia Randall, Office of 
Research Reporting and Public 
Response, National Institute of Allergy 
and Infectious Diseases, Building 31, 
room 7A32, National Institutes of 
Health, Bethesda, Maryland 20892, 
telephone (301-496-5717), will provide a 
summary of the meeting and a roster of 
the committee members upon request. 
Dr. Kamal K. Mittal, Executive 
Secretary, Allergy Immunology and 
Transplantation Research Committee, 
NIAID, NIH, Westwood Building, room 
3A06, Bethesda, Maryland 20892, 
telephone (301-496-3528), will provide 
substantive program information, 
(Catalog of Federal Domestic Assistance 
Program Nos. 13.855, Pharmacological 
Sciences; 13.856, Microbiology and Infectious 
Diseases Research, National Institutes of 
Health.) 
Dated; August 29, 1990. 
Betty J. Beveridge, 
Committee Management Officer, NIH. 
[FR Doc. 90-21621 Filed 9-13-90; 8:45 am] 
BILLING CODE 4140-01-M 
National Institute of Allergy and 
Infectious Diseases; Meeting 
Pursuant to Public Law 92-463, notice 
is hereby given of the meeting of the 
Transplantation Biology and 
Immunology Subcommittee of the 
Allergy, Immunology, and 
Transplantation Research Committee, 
National Institute of Allergy and 
Infectious Diseases, on October 15-17 
1990, in Conlerence Room 7, Building 
31C, at National Institutes of Health, 
Bethesda, Maryland 20892. 
The meeting will be open to the public 
from 8:30 a.m. to 10 a.m. on October 15, 
to discuss administrative details relating 
to committee business and for program 
review. Attendance by the public will be 
limited to space available. In 
[314] 
Recombinant DNA Research, Volume 14 
